Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Gretchen S. Johns"'
Autor:
Yu Wu, DNP, APRN, Aaron C. Spaulding, PhD, Shalmali Borkar, MPH, Michelle M. Shoaei, MBA, Maria Mendoza, MSN, RN, Rhonda L. Grant, MT (ASCP), Bruce W. Barber, MT (ASCP), Gretchen S. Johns, MD, Pablo Moreno Franco, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 72-83 (2021)
Objective: To reduce diagnostic blood loss by using small volume tubes for routine laboratory testing throughout the hospital, as blood loss from laboratory testing can be substantial for patients and may lead to hospital-acquired anemia. Patients an
Externí odkaz:
https://doaj.org/article/0c92e450b86a42c3889cc87fdc126a82
Publikováno v:
Vaccines, Vol 9, Iss 8, p 903 (2021)
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is a critical strategy to overcome the COVID-19 pandemic. Multiple SARS-CoV-2 vaccines have been developed i
Externí odkaz:
https://doaj.org/article/5bb74d1eb73049a9956c60c51358f047
Publikováno v:
Acta Medica Academica, Vol 40, Iss 2, Pp 152-158 (2011)
Objective. To evaluate if increasingly elevated levels of plasma D-dimer are associated with higher prevalence of acute pulmonaryembolus (PE). Patients and Methods. A retrospective study wasconducted evaluating all PE protocol CT examinations perform
Externí odkaz:
https://doaj.org/article/446be65b67b946a6835e38bba499969a
Autor:
Rhonda Grant, Gretchen S. Johns, Aaron Spaulding, Michelle M. Shoaei, Shalmali R. Borkar, Bruce W. Barber, Yu Wu, Pablo Moreno Franco, Maria Mendoza
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 72-83 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 72-83 (2021)
Objective To reduce diagnostic blood loss by using small volume tubes for routine laboratory testing throughout the hospital, as blood loss from laboratory testing can be substantial for patients and may lead to hospital-acquired anemia. Patients and
Publikováno v:
Vaccines, Vol 9, Iss 903, p 903 (2021)
Vaccines
Vaccines
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is a critical strategy to overcome the COVID-19 pandemic. Multiple SARS-CoV-2 vaccines have been developed i
Autor:
Steve R. Ommen, Michael J. Ackerman, Colleen S. Thomas, Joseph L. Blackshear, Gretchen S. Johns, Jeffrey B. Geske, Brian P. Shapiro, J. Martijn Bos, Robert E. Safford
Publikováno v:
The American Journal of Cardiology. 121:768-774
To test dual blood biomarkers compared with electrocardiogram (ECG) for hypertrophic cardiomyopathy (HC) screening, we performed 3 analyses and cut-point assessments. First, we measured platelet function analyzer (PFA)-100 (n = 99) and normalized B-t
Publikováno v:
Critical Care Medicine. 48:654-654
Autor:
Joseph L. Blackshear, Ewa M. Wysokinska, Gretchen S. Johns, Dong Chen, Brian P. Shapiro, Pragnesh Parikh, Steven Ung, Colleen S. Thomas, Robert E. Safford, Mark E. Stark
Publikováno v:
Journal of Thrombosis and Haemostasis. 12:1966-1974
SummaryBackground Mitral valve regurgitation is associated with an acquired hemostatic defect. Objective We sought to assess the prevalence and severity of acquired von Willebrand syndrome in patients with native valve mitral regurgitation (MR). Pati
Publikováno v:
Blood Coagulation & Fibrinolysis. 26:961-963
Orthotopic liver transplantation for other diseases typically results in a coincidental cure for hemophilia A and B; however, long-term outcomes of liver transplant in hemophilia C are not very well described. Herein, the authors report a patient of
Autor:
K.L. Venkatachalam, David Snipelisky, Karin Prussak, Gretchen S. Johns, Fred Kusumoto, Christine Kauffman
Publikováno v:
Journal of Interventional Cardiac Electrophysiology. 35:29-33
Although warfarin has traditionally been used for reducing risk of stroke in patients with atrial fibrillation, over the past year, the direct thrombin inhibitor dabigatran has become an accepted alternative. No study has conclusively investigated bl